Dagher, C.; Akiki, M.; Swanson, K.; Carollo, B.; Farber, H.W.; Parikh, R.
Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease. Life 2025, 15, 974.
https://doi.org/10.3390/life15060974
AMA Style
Dagher C, Akiki M, Swanson K, Carollo B, Farber HW, Parikh R.
Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease. Life. 2025; 15(6):974.
https://doi.org/10.3390/life15060974
Chicago/Turabian Style
Dagher, Chebly, Maria Akiki, Kristen Swanson, Brett Carollo, Harrison W. Farber, and Raj Parikh.
2025. "Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease" Life 15, no. 6: 974.
https://doi.org/10.3390/life15060974
APA Style
Dagher, C., Akiki, M., Swanson, K., Carollo, B., Farber, H. W., & Parikh, R.
(2025). Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease. Life, 15(6), 974.
https://doi.org/10.3390/life15060974
